(Last updated: 23/05/2022) -- for sponsorships and media partnerships, reach out at info@biopharmatrend.com Artificial intelligence (machine learning and deep learning, …
Second novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI’s drug discovery platform and selected for AstraZeneca’s drug development …
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
BenevolentAI, a leading clinical-stage artificial intelligence (AI) enabled drug discovery company, and Drugs for Neglected Disease initiative (DNDi), a not-for-profit …
Day 1 (How Advanced Technologies Are Shaping Pharmaceutical Industry) Disruptive technologies and emerging trends such as robotics, artificial intelligence, precision …
eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services that accelerate digital clinical initiatives, …
This website uses cookies
We use cookies to personalise content and to analyse our traffic. We also share information about your use of our site
with our analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected
from your use of their services. You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.